Thykamine

N/A

Report date: 2022/07/18 15:43:34
NME

Base Information

Drug NameThykamine
Drug Alias NamePCT-233PUR-0110
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionInterleukin-10 modulatorsTumor necrosis factor α modulators
TargetsTumor necrosis factor αInterleukin-10
Therapy Area/IndicationsProctocolitisColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPurgenesis Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPurgenesis Technologies Inc
Active IndicationsN/A
Inactive IndicationsProctocolitisColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A